作者: Raymond Pratt
DOI:
关键词:
摘要: The invention describes novel methods for treating and preventing dementia caused by vascular diseases; associated with Parkinson's disease; Lewy Body dementia; AIDS mild cognitive impairments; age-associated memory impairments and/or neurologic psychiatric conditions, including epilepsy, brain tumors, lesions, multiple sclerosis, Down's syndrome, Rett's progressive supranuclear palsy, frontal lobe schizophrenia related disorders; traumatic injury, post coronary artery by-pass graft surgery, electroconvulsive shock therapy, chemotherapy, administering a therapeutically effective amount of at least one the cholinesterase inhibitor compounds described herein. also delirium, Tourette's myasthenia gravis, attention deficit hyperactivity disorder, autism, dyslexia, mania, depression, apathy, myopathy diabetes delaying onset Alzheimer's disease, enhancing functions, sleep apnea, alleviating tobacco withdrawal dysfunctions Huntington's Disease A preferred use in is donepezil hydrochloride or ARICEPT®.